Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081342 | SCV000113272 | benign | not specified | 2013-08-09 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081342 | SCV000153535 | benign | not specified | 2016-01-17 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000081342 | SCV000202083 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | Val871Met in Exon 08 of WFS1: This variant is not expected to have clinical sign ificance because it has been identified in 1.1% (75/7020) of European American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs71532874). |
Gene |
RCV000421798 | SCV000252503 | benign | not provided | 2019-04-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20981092, 25262649, 12107816, 15605410, 20875904, 25895475, 30245029) |
Genomic Diagnostic Laboratory, |
RCV000081342 | SCV000297200 | benign | not specified | 2015-11-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000081342 | SCV000311330 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000342228 | SCV000450707 | benign | Autosomal dominant nonsyndromic hearing loss 6 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000421798 | SCV000511248 | benign | not provided | 2016-12-30 | criteria provided, single submitter | clinical testing | |
Personalized Diabetes Medicine Program, |
RCV000445441 | SCV000537023 | benign | Monogenic diabetes | 2018-12-07 | criteria provided, single submitter | research | ACMG criteria: BS2 (16 homozygotes in gnomAD), BS1 (allele frequency is 0.01358 of gnomAD European Finish, which means carrier frequency is 0.0018, above the disease frequency of 1/5000 for WFS)= benign; REVEL 0.255 + PP3/6 predictors + BP4/5 predictors= conflicting evidence, not using |
ARUP Laboratories, |
RCV000421798 | SCV000605608 | benign | not provided | 2023-09-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000421798 | SCV000844885 | benign | not provided | 2018-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000421798 | SCV001013354 | benign | not provided | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001156285 | SCV001317773 | benign | WFS1-Related Spectrum Disorders | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Clinical Genomics, |
RCV002464106 | SCV002626370 | uncertain significance | Wolfram syndrome 1 | criteria provided, single submitter | research | Mutations in WFS1 gene are associated with Wolfram's syndrome, an autosomal recessive condition, which cause diabetes mellitus, diabetes insipidus, deafness and optic atrophy. rs71532874 variant is also seen in patients with Diabetes Mellitus. However, the role of this particular variant is yet to be ascertained. | |
Fulgent Genetics, |
RCV002498427 | SCV002805272 | likely benign | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2022-04-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000421798 | SCV004011522 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | WFS1: PM5, BS1, BS2 |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000081342 | SCV001953102 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000081342 | SCV001972770 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000421798 | SCV002036980 | likely benign | not provided | no assertion criteria provided | clinical testing |